Literature DB >> 22718338

Aggressive classical Kaposi's sarcoma mimicking malignant lymphoma.

Eun Haeng Jeong1, Dong Hoe Koo, Sang Hyuk Lee, Ki Bae Bang, Eun Hye Park, Ji Soo Seol, Ji Yong Lee, Jung Soo Pyo, Dong Hoon Kim, Hee Jin Lee, Sukjoong Oh.   

Abstract

Classical Kaposi's sarcoma is an unusual multifocal neoplasm of vascular endothelial cell origin, and considered a less malignant, slowly-progressing tumor. Although visceral involvement is occasionally seen in HIV/AIDS patients with KS, tumor dissemination to visceral lymph nodes in classical KS is very rare. A 72-year-old woman without any other relevant past medical history presented with anorexia, weight loss, night sweats, and skin eruptions. As the rapid progression of cytopenias and lymphadenopathy were observed, bone marrow biopsy and imaging were performed. Positron emission tomography showed disseminated lymphadenopathy in the cervical, axillary, mediastinal, inguinal, and abdomino-pelvic nodal areas. Inguinal lymph node biopsy was compatible with KS, positive for CD31, CD34, and human herpesvirus-8 by immunohistochemical stain. We report a case of aggressive classical KS mimicking aggressive malignant lymphoma.

Entities:  

Mesh:

Year:  2012        PMID: 22718338     DOI: 10.1007/s12253-012-9545-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  14 in total

1.  Identification of human herpesvirus 8-specific cytotoxic T-cell responses.

Authors:  M Osman; T Kubo; J Gill; F Neipel; M Becker; G Smith; R Weiss; B Gazzard; C Boshoff; F Gotch
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  Kaposi's sarcoma.

Authors:  K Antman; Y Chang
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

Review 3.  Treatment of Kaposi's sarcoma.

Authors:  J H Von Roenn; M Cianfrocca
Journal:  Cancer Treat Res       Date:  2001

4.  Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines.

Authors:  B Brenner; E Rakowsky; A Katz; H Gutman; A Sulkes; J Schacter; E Fenig
Journal:  Int J Oncol       Date:  1999-06       Impact factor: 5.650

5.  Classical Kaposi sarcoma: prognostic factor analysis of 248 patients.

Authors:  Baruch Brenner; Alina Weissmann-Brenner; Erica Rakowsky; Sara Weltfriend; Eyal Fenig; Rachel Friedman-Birnbaum; Aaron Sulkes; Shai Linn
Journal:  Cancer       Date:  2002-11-01       Impact factor: 6.860

6.  Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.

Authors:  Giuseppe Di Lorenzo; Alexander Kreuter; Rossella Di Trolio; Attilio Guarini; Carmela Romano; Vincenzo Montesarchio; Norbert H Brockmeyer; Sabino De Placido; Mark Bower; Bruce J Dezube
Journal:  J Invest Dermatol       Date:  2008-01-10       Impact factor: 8.551

7.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.

Authors:  L Brambilla; A Romanelli; M Bellinvia; S Ferrucci; M Vinci; V Boneschi; A Miedico; L Tedeschi
Journal:  Br J Dermatol       Date:  2008-03-20       Impact factor: 9.302

Review 9.  AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?

Authors:  Susan E Krown
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-25       Impact factor: 7.638

10.  Important role of gemcitabine in the treatment of classic Kaposi's sarcoma.

Authors:  Fable Zustovich; Giuseppe Lombardi; Davide Pastorelli
Journal:  Tumori       Date:  2009 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.